BioCorRx Inc.
BICX
$0.34
$0.013.03%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 876.80K | 797.20K | 948.30K | 313.10K | 138.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 876.80K | 797.20K | 948.30K | 313.10K | 138.90K |
| Cost of Revenue | 47.00K | 21.80K | 358.80K | 0.00 | 0.00 |
| Gross Profit | 829.90K | 775.40K | 589.50K | 313.10K | 138.90K |
| SG&A Expenses | 3.68M | 3.79M | 4.09M | 4.14M | 3.75M |
| Depreciation & Amortization | 30.40K | 44.00K | 181.80K | 116.50K | 51.20K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.72M | 5.63M | 6.37M | 5.45M | 5.23M |
| Operating Income | -4.84M | -4.83M | -5.42M | -5.14M | -5.09M |
| Income Before Tax | -3.52M | -3.51M | -4.27M | -4.97M | -4.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.52 | -3.51 | -4.27 | -4.97 | -4.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 87.00K | 68.70K | -892.10K | 242.90K | 115.70K |
| Net Income | -3.43M | -3.44M | -5.16M | -4.73M | -4.71M |
| EBIT | -4.84M | -4.83M | -5.42M | -5.14M | -5.09M |
| EBITDA | -4.68M | -4.65M | -5.24M | -5.02M | -5.04M |
| EPS Basic | -0.19 | -0.21 | -0.33 | -0.36 | -0.41 |
| Normalized Basic EPS | -0.11 | -0.13 | -0.21 | -0.20 | -0.24 |
| EPS Diluted | -0.19 | -0.21 | -0.33 | -0.36 | -0.41 |
| Normalized Diluted EPS | -0.11 | -0.13 | -0.21 | -0.20 | -0.24 |
| Average Basic Shares Outstanding | 84.01M | 73.51M | 62.99M | 55.73M | 48.18M |
| Average Diluted Shares Outstanding | 84.01M | 73.51M | 62.99M | 55.73M | 48.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |